Impact of Lowering Low-Density Lipoprotein Cholesterol with Contemporary Lipid-Lowering Medicines on Cognitive Function: A Systematic Review and Meta-Analysis
ConclusionsContemporary lipid-lowering medicines were not associated with cognitive impairment in RCTs. A low LDL-C level did not influence the incidence of cognitive disorder or global cognitive performance.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Brain | Cardiology | Cardiovascular | Cholesterol | Databases & Libraries | Heart | Neurology | Neuroscience | Science | Statin Therapy | Study | Vytorin | Zetia